Subscribe to Newsletter

Clinical Trials

Business & Regulation Advanced Medicine

Leadership in Times of Crisis

| Stephanie Vine

Experts from our previous Power Lists discuss the challenges of leadership during these trying times.

Manufacture Small Molecules

Two Grand Challenges for Pharma

| Stephanie Vine

A pair of medicines manufacturing initiatives are looking to improve continuous direct compression and clinical trial supply.

Manufacture Vaccines

COVID-19: Vaccine Development at Full Tilt

| Sheila Rocchio

Will the rapid development of COVID-19 vaccines lead to unsafe therapies?

Business & Regulation COVID-19

Cutting Through the Noise

| Stephanie Vine

We curate the COVID-19 news and breakthroughs of 2020 to bring you a helicopter view of the global fight against COVID-19.

Discovery & Development Clinical Trials

Green Trials

| Stephanie Vine

Implementing green practices in clinical trials.

Discovery & Development Vaccines

The Pfizer COVID-19 Vaccine

| Stephanie Vine

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

Discovery & Development Clinical Trials

Pandemic Protection

| Stephanie Vine

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Manufacture Vaccines

Don’t Exclude the Aged

| Stephanie Vine

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

Manufacture Bioprocessing - Single Use Systems

The Power List 2021: Nominate Now

| Stephanie Vine

Nominations are now open for The Medicine Maker 2021 Power List.

Discovery & Development Clinical Trials

A Matter of Trust

| Maryam Mahdi

Can we trust the integrity of clinical trials?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register